Catherine L. Nutt

4.0k total citations · 1 hit paper
26 papers, 3.0k citations indexed

About

Catherine L. Nutt is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Catherine L. Nutt has authored 26 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Genetics and 9 papers in Oncology. Recurrent topics in Catherine L. Nutt's work include Glioma Diagnosis and Treatment (11 papers), Epigenetics and DNA Methylation (4 papers) and Molecular Biology Techniques and Applications (3 papers). Catherine L. Nutt is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Epigenetics and DNA Methylation (4 papers) and Molecular Biology Techniques and Applications (3 papers). Catherine L. Nutt collaborates with scholars based in United States, Canada and Germany. Catherine L. Nutt's co-authors include David N. Louis, Rebecca A. Betensky, Tracy T. Batchelor, J. Gregory Cairncross, Andreas von Deimling, A. John Iafrate, Masahiro Mizoguchi, Keith L. Ligon, David H. Rowitch and Peter M. Black and has published in prestigious journals such as Journal of Neuroscience, Cancer Research and Oncogene.

In The Last Decade

Catherine L. Nutt

26 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

2003 719 citations Catherine L. Nutt, D.R. Mani et al. PubMed profile →

Peers

Catherine L. Nutt

GENET

ONCOL

PRM

Inmaculada Spiteri United Kingdom

Esther Schmidt Germany

Anjan Misra United States

Sonika Dahiya United States

Stephen Yip Canada

William F. Forrest United States

Grischa Toedt Germany

Ruihuan Chen China

Yuri Kotliarov United States

Wei Keat Lim United States

Inmaculada Spiteri United Kingdom

Catherine L. Nutt

2.6k ×1.5

845 ×0.7

GENET

2.2k ×2.3

616 ×0.9

ONCOL

248 ×0.8

PRM

Citations per year, relative to Catherine L. Nutt Catherine L. Nutt (= 1×) peers Inmaculada Spiteri

Countries citing papers authored by Catherine L. Nutt

Since Specialization

Citations

This map shows the geographic impact of Catherine L. Nutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine L. Nutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine L. Nutt more than expected).

Fields of papers citing papers by Catherine L. Nutt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine L. Nutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine L. Nutt. The network helps show where Catherine L. Nutt may publish in the future.

Co-authorship network of co-authors of Catherine L. Nutt

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine L. Nutt. A scholar is included among the top collaborators of Catherine L. Nutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine L. Nutt. Catherine L. Nutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nutt, Catherine L., et al.. (2018). REFERENCE VALUES FOR GLENOHUMERAL JOINT ROTATIONAL RANGE OF MOTION IN ELITE TENNIS PLAYERS. International Journal of Sports Physical Therapy. 13(3). 501–510. 7 indexed citations

DeSantis, Stacia M., E. Andrés Houseman, Brent A. Coull, Catherine L. Nutt, & Rebecca A. Betensky. (2012). Supervised Bayesian latent class models for high‐dimensional data. Statistics in Medicine. 31(13). 1342–1360. 7 indexed citations

Camelo‐Piragua, Sandra, Michael Jansen, Aniruddha Ganguly, et al.. (2011). A Sensitive and Specific Diagnostic Panel to Distinguish Diffuse Astrocytoma From Astrocytosis: Chromosome 7 Gain With Mutant Isocitrate Dehydrogenase 1 and p53. Journal of Neuropathology & Experimental Neurology. 70(2). 110–115. 61 indexed citations

Yip, Stephen, Jiangyong Miao, Daniel P. Cahill, et al.. (2009). MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance. Clinical Cancer Research. 15(14). 4622–4629. 292 indexed citations

Colman, Howard, Lin Zhang, Erik P. Sulman, et al.. (2009). A multigene predictor of outcome in glioblastoma. Neuro-Oncology. 12(1). 49–57. 285 indexed citations

Tang, Nan, Helen Deng, Renee Head, et al.. (2009). Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide. Clinical Cancer Research. 15(8). 2777–2788. 133 indexed citations

Iglesia, Núria de la, Geneviève Konopka, Kah‐Leong Lim, et al.. (2008). Deregulation of a STAT3-Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness. Journal of Neuroscience. 28(23). 5870–5878. 138 indexed citations

Mizoguchi, Masahiro, et al.. (2006). Activation of STAT3, MAPK, and AKT in Malignant Astrocytic Gliomas. Journal of Neuropathology & Experimental Neurology. 65(12). 1181–1188. 147 indexed citations

Mueller, Wolf, Catherine L. Nutt, Mathias Ehrich, et al.. (2006). Downregulation of RUNX3 and TES by hypermethylation in glioblastoma. Oncogene. 26(4). 583–593. 103 indexed citations

10.

Rousseau, Audrey, Catherine L. Nutt, Rebecca A. Betensky, et al.. (2006). Expression of Oligodendroglial and Astrocytic Lineage Markers in Diffuse Gliomas. Journal of Neuropathology & Experimental Neurology. 65(12). 1149–1156. 57 indexed citations

11.

Ma, Deqin, et al.. (2005). Autocrine Platelet-Derived Growth Factor–Dependent Gene Expression in Glioblastoma Cells Is Mediated Largely by Activation of the Transcription Factor Sterol Regulatory Element Binding Protein and Is Associated with Altered Genotype and Patient Survival in Human Brain Tumors. Cancer Research. 65(13). 5523–5534. 27 indexed citations

12.

Dong, Shumin, Catherine L. Nutt, Rebecca A. Betensky, et al.. (2005). Histology-Based Expression Profiling Yields Novel Prognostic Markers in Human Glioblastoma. Journal of Neuropathology & Experimental Neurology. 64(11). 948–955. 77 indexed citations

13.

Betensky, Rebecca A., Catherine L. Nutt, Tracy T. Batchelor, & David N. Louis. (2005). Statistical Considerations for Immunohistochemistry Panel Development after Gene Expression Profiling of Human Cancers. Journal of Molecular Diagnostics. 7(2). 276–282. 2 indexed citations

14.

Nutt, Catherine L.. (2005). Molecular genetics of oligodendrogliomas: a model for improved clinical management in the field of neurooncology. Neurosurgical FOCUS. 19(5). 1–9. 13 indexed citations

15.

Mizoguchi, Masahiro, Catherine L. Nutt, Gayatry Mohapatra, & David N. Louis. (2004). Genetic Alterations of Phosphoinositide 3‐kinase Subunit Genes in Human Glioblastomas. Brain Pathology. 14(4). 372–377. 110 indexed citations

16.

Ligon, Keith L., John A. Alberta, Alvin T. Kho, et al.. (2004). The Oligodendroglial Lineage Marker OLIG2 Is Universally Expressed in Diffuse Gliomas. Journal of Neuropathology & Experimental Neurology. 63(5). 499–509. 319 indexed citations

17.

Nutt, Catherine L., D.R. Mani, Rebecca A. Betensky, et al.. (2003). Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.. PubMed. 63(7). 1602–7. 719 indexed citations breakdown →

18.

Nutt, Catherine L., Mark Noble, Ann F. Chambers, & J. Gregory Cairncross. (2000). Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy.. PubMed. 60(17). 4812–8. 81 indexed citations

19.

Nutt, Catherine L., et al.. (1999). O 6 -Methylguanine-DNA methyltransferase activity, p53 gene status and BCNU resistance in mouse astrocytes. Carcinogenesis. 20(12). 2361–2365. 14 indexed citations

20.

Nutt, Catherine L., J Costello, Linda L. Bambrick, et al.. (1995). O⁶-Methylguanine-DNA Methyltransferase in Tumors and Cells of the Oligodendrocyte Lineage. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 22(2). 111–115. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact